NuVasive (NUVA) Reports In-Line Q4 EPS; Slight Miss on Revenues

Go back to NuVasive (NUVA) Reports In-Line Q4 EPS; Slight Miss on Revenues

NuVasive (NUVA) PT Raised to $52 at Leerink Partners

February 27, 2018 7:31 AM EST

Leerink Partners raised its price target on NuVasive (NASDAQ: NUVA) to $52.00 (from $51.00) while maintaining a Market Perform rating.

... More

NuVasive (NUVA) PT Lowered to $70 at Needham & Company, Keeps 'Buy'

February 27, 2018 6:44 AM EST

Needham & Company lowered its price target on NuVasive (NASDAQ: NUVA) to $70.00 (from $71.00) while maintaining a Buy rating.

Analsyt Mike Matson commented, "NUVA's 4Q17 revenue was consistent with its 1/8/18 preannouncement and EPS met consensus. Management's 2018 guidance was above consensus although we do not believe... More